HR
APGNW

Howe & Rusling’s Apexigen, Inc. WarrantApexigen, Inc. Warrant APGNW Stock Holding History

Howe & Rusling’s Portfolio APGNW Stock Details APGNW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-45
Closed – – 1116
2022
Q3 		$0 Buy
+45
New +$11 ﹤0.01% 1227

Other funds holding APGNW

RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
KC
Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
YCM
Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return
SM
Skaana Management Brooklyn, New York $296M AUM 65.1% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

Howe & Rusling's APGNW Position: Q4 2022 in Review

Howe & Rusling sold out of Apexigen, Inc. WarrantApexigen, Inc. Warrant (APGNW) in Q4 2022, closing a stake of 45 shares.

Howe & Rusling first reported a position in APGNW in Q3 2022 and held it in 1 quarter. The position peaked at $0 in Q3 2022. 18 funds tracked by Wall St. Rank hold APGNW as of Q4 2022.

  • Howe & Rusling reported no remaining Apexigen, Inc. WarrantApexigen, Inc. Warrant position as of Q4 2022 after selling out during the quarter.
  • Howe & Rusling sold 45 Apexigen, Inc. WarrantApexigen, Inc. Warrant shares in Q4 2022.
  • Howe & Rusling first reported a position in Apexigen, Inc. WarrantApexigen, Inc. Warrant in Q3 2022 and held it in 1 quarter.
  • Howe & Rusling's Apexigen, Inc. WarrantApexigen, Inc. Warrant position peaked at $0 in Q3 2022.
  • 18 funds tracked by Wall St. Rank held Apexigen, Inc. WarrantApexigen, Inc. Warrant as of Q4 2022.

Based on Howe & Rusling's 13F filing for Q4 2022, filed 15 Feb 2023.